Omnicell Inc (OMCL)
27.44
-1.02
(-3.58%)
USD |
NASDAQ |
Apr 24, 16:00
27.44
0.00 (0.00%)
After-Hours: 19:10
Omnicell Cash from Financing (TTM): 23.42M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 23.42M |
September 30, 2023 | 13.85M |
June 30, 2023 | 20.08M |
March 31, 2023 | 15.03M |
December 31, 2022 | -20.95M |
September 30, 2022 | -17.85M |
June 30, 2022 | -8.621M |
March 31, 2022 | -0.355M |
December 31, 2021 | 47.36M |
September 30, 2021 | 61.10M |
June 30, 2021 | 510.99M |
March 31, 2021 | 505.63M |
December 31, 2020 | 456.27M |
September 30, 2020 | 405.35M |
June 30, 2020 | -54.20M |
March 31, 2020 | -57.07M |
December 31, 2019 | -23.48M |
September 30, 2019 | -3.633M |
June 30, 2019 | -15.74M |
March 31, 2019 | -19.52M |
December 31, 2018 | -13.60M |
September 30, 2018 | 29.27M |
June 30, 2018 | 38.03M |
March 31, 2018 | 26.00M |
December 31, 2017 | -9.877M |
Date | Value |
---|---|
September 30, 2017 | -11.96M |
June 30, 2017 | -12.23M |
March 31, 2017 | 4.79M |
December 31, 2016 | 263.75M |
September 30, 2016 | 229.79M |
June 30, 2016 | 206.55M |
March 31, 2016 | 185.69M |
December 31, 2015 | -36.56M |
September 30, 2015 | -36.44M |
June 30, 2015 | -24.02M |
March 31, 2015 | -1.124M |
December 31, 2014 | -0.206M |
September 30, 2014 | -15.94M |
June 30, 2014 | 3.908M |
March 31, 2014 | 6.208M |
December 31, 2013 | 7.374M |
September 30, 2013 | 29.86M |
June 30, 2013 | 15.11M |
March 31, 2013 | 4.611M |
December 31, 2012 | -0.232M |
September 30, 2012 | -4.69M |
June 30, 2012 | -2.502M |
March 31, 2012 | 2.786M |
December 31, 2011 | -1.84M |
September 30, 2011 | -2.608M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-57.07M
Minimum
Mar 2020
510.99M
Maximum
Jun 2021
97.75M
Average
13.85M
Median
Sep 2023
Cash from Financing (TTM) Benchmarks
Teladoc Health Inc | 10.85M |
American Shared Hospital Services | 1.91M |
Novo Integrated Sciences Inc | 4.668M |
Astrana Health Inc | 3.421M |
Cryo-Cell International Inc | -0.7611M |